Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Preclinical Phase
Recent news which mentions Preclinical Phase
< Previous
1
2
3
4
Next >
PharmaCyte Updates Status Of Investigational New Drug Application For Pancreatic Cancer Candidate
February 14, 2022
Tickers
PMCB
Tags
Penny Stocks
Market News
Health Care
From
Benzinga
ImmunoPrecise's COVID-19 Antibody Cocktail Shows Neutralization Activity Against Omicron
January 31, 2022
Tickers
IPA
Tags
Trading Ideas
Briefs
IPA
From
Benzinga
IDEAYA Advances IDE161 Into IND-Enabling Studies, Exercises Licensing Option For PARG Inhibitors
January 31, 2022
Tickers
IDYA
Tags
IDYA
Preclinical Phase
Briefs
From
Benzinga
Alterity Therapeutics Highlights New Publications On ATH434 In Parkinson's Disease
January 28, 2022
Tickers
ATHE
Tags
Health Care
Movers
Market News
From
Benzinga
Immix Biopharma's IMX-110 / Anti-PD-1 Combo Therapy Shows Extended Median Survival In Animal Studies
January 25, 2022
Tickers
BGNE
IMMX
Tags
IMMX
General
News
From
Benzinga
HCW Biologics Lead Candidate Shows Preclinical Anti-Tumor Activity, Reduced Side Effects of Chemo
January 20, 2022
Tickers
HCWB
Tags
Market News
Movers
Health Care
From
Benzinga
Can Fite's Piclidenoson Destroys Pathological Skin Cells, Lab Study Shows
January 13, 2022
Tickers
CANF
Tags
Penny Stocks
General
News
From
Benzinga
Heat Biologics Issues New PTX-35 Preclinical Data In Organ Transplantation, Update On HS-110
January 12, 2022
Tickers
HTBX
Tags
Biotech
Benzinga
Preclinical Phase
From
Benzinga
Immix's Lead Program Shows 50% Response Rate In Resistant Cancer In Animal Study
January 12, 2022
Tickers
IMMX
Tags
Preclinical Phase
Biotech
why it's moving
From
Benzinga
EXCLUSIVE: New On NASDAQ Deck, Revelation Bio's COVID-19 Antiviral Shows Encouraging Preclinical Action
January 11, 2022
Tickers
IPOS
PAIC
REVB
Tags
REVB
Preclinical Phase
Benzinga
From
Benzinga
See Why Lixte Biotech Shares Trading At Over 100%?
January 05, 2022
Tickers
LIXT
Tags
Health Care
Market News
Short Ideas
From
Benzinga
Why Hoth Therapeutics Stock Is Soaring Today?
January 04, 2022
Tickers
HOTH
Tags
Trading Ideas
General
News
From
Benzinga
Tonix Pharma, Kansas University Join Forces To Work On Next-Gen mRNA-Based COVID-19 Vaccine
January 04, 2022
Tickers
BNTX
MRNA
PFE
TNXP
Tags
Health Care
Movers
Contracts
From
Benzinga
BiondVax Shares Skyrocket After It Plans To In-License Nanosized COVID-19 Antibody
December 22, 2021
Tickers
BVXV
Tags
Market News
Contracts
Movers
From
Benzinga
Aridis Stock Rallies After Positive Preclinical Data For COVID-19 Antibody Against Omicron
December 21, 2021
Tickers
ARDS
Tags
Penny Stocks
Long Ideas
News
From
Benzinga
Oragenics Extends Collaboration with NRC Canada For Omicron-Specific Vaccine
December 20, 2021
Tickers
OGEN
Tags
General
News
Long Ideas
From
Benzinga
Why Are Vir Biotech Shares Gaining Today?
December 15, 2021
Tickers
GSK
VIR
Tags
COVID/19 Coronavirus
Contracts
Market News
From
Benzinga
Generation Bio Hits 52-Week Low After Preclinical Data From Hemophilia A Program
December 14, 2021
Tickers
GBIO
Tags
why it's moving
Benzinga
Biotech
From
Benzinga
iTeos Posts New Preclinical Data For Anti-TIGIT Antibody At ASH 2021
December 10, 2021
Tickers
ITOS
Tags
Market News
ITOS
Health Care
From
Benzinga
Anixa Biosciences Says COVID-19 Compounds Potentially Effective Against Omicron Variant
December 07, 2021
Tickers
ANIX
Tags
News
General
Penny Stocks
From
Benzinga
Taysha Gene's Epilepsy Candidate Shows Encouraging Action In Preclinical Studies
December 07, 2021
Tickers
TSHA
Tags
Market News
Health Care
Movers
From
Benzinga
Preclinical Data Shows GSK-Vir COVID-19 Drug Works Against All Omicron Mutations
December 07, 2021
Tickers
GSK
VIR
Tags
COVID/19 Coronavirus
Health Care
Movers
From
Benzinga
Codiak's COVID-19 Vaccine Hopeful Shows Potential In Preclinical Study
December 02, 2021
Tickers
CDAK
Tags
Briefs
General
News
From
Benzinga
Oragenics COVID-19 Vaccine Candidate Shows Encouraging Preclinical Action
December 01, 2021
Tickers
OGEN
Tags
Trading Ideas
Briefs
General
From
Benzinga
Why Are Qualigen Therapeutics Shares Surging During Premarket Tuesday?
November 23, 2021
Tickers
QLGN
Tags
Briefs
Trading Ideas
News
From
Benzinga
RegenXbio's Duchenne Gene Therapy Secures FDA Orphan Drug Tag
November 22, 2021
Tickers
RGNX
Tags
Market News
Health Care
News
From
Benzinga
Voyager Therapeutics's Cancer Antibody Program Shows Encouraging Preclinical Action
November 19, 2021
Tickers
VYGR
Tags
Penny Stocks
Market News
Movers
From
Benzinga
Armata Shares Surge As FDA Gives Green Signal To Its Second Program To Enter Human Trial(s)
November 18, 2021
Tickers
ARMP
Tags
Trading Ideas
Briefs
General
From
Benzinga
VYNE Therapeutics' BET Inhibitor Shows Encouraging Preclinical Action
October 26, 2021
Tickers
VYNE
Tags
Preclinical Phase
Biotech
Benzinga
From
Benzinga
Adial Pharma-Backed Purnovate Selects PNV-5030 As Pain Management Candidate
October 21, 2021
Tickers
ADIL
Tags
Briefs
Trading Ideas
General
From
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.